| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | Plasmodium vivax Reticulocyte binding protein 2 (a.a.61-460) |
| | Swiss-Prot #: | Q5DSD7 |
| | Entry name: | Q5DSD7_PLAVI |
| | Protein | Reticulocyte binding protein 2 |
| | Gene names: |
| | Organism: | Plasmodium vivax |
| | Codon-optimized cDNA Clone |
| | Cat#: | RPL-0537 |
| | Description: | Applications:1. Codon-optimized cDNA sequence designed for recombinant |
| | protein production in both E.coli and Mammalian cell. The cDNA has been |
| | cloned into E.coli expression vector with 6x Histidine tag. 2. May be used as |
| | RNAi assistance to restore the loss-of-function. |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Recombinant Protein |
| | Cat#: | PL-0537 |
| | Source: | Recombinant protein derived from E.coli. Or Yeast |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Purity: | > 90%, as determined by SDS-PAGE under reducing conditions |
| | Activity: | N/A |
| | Applications: | Western Blot, may be used for other applications determined by |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Sequence: | | MEKNVLWVIF YNFLVILLAS CNDSNRSKSN SLKSESKSLP TYANLMRNGQ HKYNNAKTED NIGNQINNDN NHNGYNDNRT |
| | NSEYPKTSHL QHSPSLVHLN DHKFTAKPSR HAYIQRNSIY TLNTNNNMEN TNNESHTVPN LFIQKNQKAP QKPATQKKPT |
| | VQKKPTVQKK TEAPEIVYGN LDYLNTFDDT NNIISAFKPH HPIIYYFKEM EHFANSYYDL RSKIRDYFAL PMKQAFDVVE |
| | QNVKDCLKNI NELRTLMTQL ENPQNYNDIS NQYAEKVKEY KKEIEDMQNC LKDNYKQNFK AILSAKLKMN LALKDIYASW |
| | WSQLSSTDTY YDMVKRYVLE VNKFDKNTST SFMDHIKKIH NSAIDTMKKM KEELNTSLDS DRVEFIIEEI GHMVEKFNLH |
| | LSKMRYGADY IKNIDSQKIE SYVYQVELRT LFYVAAKHYA DFKFSLEHLK MFENLSKSKE KMLYSTFEKL EGDLLNKINT |
| | LMGSEQSTSD LTSIIADSEK IIKSAESLIN SSSEEIAKYA LDSNEKINEI KKNYDQNILK VREFINKSNG LITSVKGTSQ |
| | LSESDKQQIE TKIEEIKKKK DILERGNEFI NIMNEIKKKK KSNSSNSATN SKDFSDKLKE LQTEFEGLNK TIEDDLQKIK |
| | DIKVKEDEDR SMKNQIEEHL KYASDNSDKV KKLISKNNEI QNYIQKIEKL IKDAPSGKEK FTTQKTDLQN KVKTIIDEFH |
| | KDDLQLLLNS LSTFYEEHQK LYREASTIEN IKELHPKIKE EYEKLEKKNY SNIDQILHNL DANLDKLKAL EKNIVEEQTN |
| | NINKDMTDSL NKLTAEVNSL RSALDSYKAD EGHLKTYKNQ INERKEKFLS TLKEQEDDIP DGKNIYEEYN KHKGVMDNKE |
| | QKITSDINQC RENIKNAEKN REKFNTLVQT LEAHTGEKDP NVHDSLEKFK TNLENLNLSK LETEFKSLID SASTTNKQIE |
| | NIIKNIDTIK SLNFTKNSSD SSKLSLEKIK ENKADLIKKL EQHTQEIEKY TFIEKEETLP LLSDLREEKN RVQRDMSEEL |
| | ISQLNTKINA ILEYYDKSKD SFNGDDETKL EQLDEFKKEC QYVQQEIEKL TTNYKVLENK INDIINEQHE KVITLSENHI |
| | TGKDKKINEK IQQNINSLND MKTKLGLLEI NQDIKNSKDA TIKNKIQEFE NKVKTILGNI DKANNKIDEI KRVHVENKVA |
| | FDKEKVENTN FEKKKKSIEK VYEQMEKTIK ELEEMNDESN IAKEVEEAQI QYKRIFIDHD VNLMNDEVEK SKTVMEEIEL |
| | YKKEIDQIKK KMIEYNKADT SNFDYTVPYN SATQSKAKIE QFITNAKTKK GTSDASQDIK ELERIKEEVH TNLQQVKLEN |
| | NSMEEKRKQI HNMKNLLILN NSETIAKEIS NNTQNALNFS LDAKKELKKT DELLQSVEAK IAEAEAHKKK IDIALEDGQI |
| | DTEVSKIEQI NQEIMNKRDE IKSYLSEIKK YKEKCTTEIS NSKRGKDKIE FLKIFKPNED SNRNKVNINE INENIRNSEQ |
| | YLKDIEDAEK QASTKVELFN NHGTNISNIF KQSEILGEET KSKKKIKKAE DIMKEIELYN SEIQTKVNDF QENLDKLNEP |
| | HNYDDAEVEL NNDKSTNAKV LIETNLESVK HNLSEITNIK QGGEKIYSKA KDIMQKIKAT SENTAEKTLE KVKDDQSNYV |
| | NYLNQITTER NLIVTEKNRL NGIDSTITNI EGALKESKKN YEIGFLEKLE EIGKNIKLKV DITKESINST VGNFSSLFNN |
| | FDLNQYDFNK NINDYENKMG EIYNEFEGSL NKISENLRNA SENTSDYNSA KTLRLEAQKE KVNLLNKEEE ANKYLRDVKK |
| | VESFRFIFNM KESLDKINEM IKKEQLTVNE GHGNVKQLVE NIKELVDENN LSDMLKQASG KNDEIQKITH SMHKNKAKTI |
| | LGHVDTSAKY VGIKIMPELA LTELLGDSNL KNAQELIFEP KTNVPLETEH MSKNTNELDV YKNIQDAYKV ALEILAHSDE |
| | IDTKQKDSSK LIEMGNEIYL KVVLINQYKN KISSIKIKEE AVSGKIDNVS KKHSELSKIT CSDKTYDNII ALEKQTELQD |
| | LRNSFTQEKT ETNSDSKLET ITKDFESLKN ALKTLEGEVN ALKASSNDHE YVKGKSAPIN VVQTEMEKTE TGIDSLDTAL |
| | DELLQKGRKC EVSRYTLIKD TVVKEISDDT ELINTIEKNV KAYLAYVKKN YEDTVQDVLT LNEHFKEKQV SNHEPTNFDK |
| | SNKSSEELTK AVTDSKAIIS KLKGVIIEVN ENTEMNTLEI SAKEIEALYN ELKNKKTSLN EIYQTSNEVK LQEMKSNADK |
| | YIDVSKIFNT VLDTQKSKIV ANQNSINSVK GQLNGKLKEL IQADSSFTLE SIKKFNEIYS HIKTNIGELE QLQQTNKSEH |
| | DNVAKHKEKI VHLINRVESL KGDVKNHGDD QYMKKLNASL LNDNIKNTTN SINISDEELK KLLKKVEEND QLCKNNNTQN |
| | FISDIMKRVE DLNRRFTENL PEKEKLHQIE NNYNEISSIF SEINLQDVDE FVAKIHKQID AEKASVNNVR EAEKIRTAIQ |
| | For pricing and availability Click Here >>> |
| | Recombinant-Protein-Reticulocyte-binding-protein-2-Plasmodium-vivax |
| | FOR in vitro RESEARCH USE ONLY. NOT FOR USE IN HUMANS. |
|
| ||||||||||||||||||||||||||||||||||
| |||||
| For cDNA or Recombinant Protein Search (Input Cat#, Gene name, Protein Name, Accession Number |
|
Copyright Bioclone Inc All rights Reserved